PDI Announces Acquisition of InServe Support Solutions and Formation of a Medical Devices & Diagnostics Division

New Division Strengthens PDI's Presence in the Hospital Market

Sep 25, 2001, 01:00 ET from PDI

    UPPER SADDLE RIVER, N.J., Sept. 25 /PRNewswire/ -- PDI (Nasdaq:   PDII)
 announced today that it has acquired InServe(R) Support Solutions, based in
 Novato, CA, in a cash purchase transaction. InServe is the leading nationwide
 supplier of supplemental field-staffing programs for the medical devices &
 diagnostics industries. The acquisition of InServe accelerates the formation
 of PDI's Medical Devices & Diagnostics Division, which will allow PDI to
 expand its reach into both medical device and diagnostics companies and the
 hospital market.
     InServe provides hands-on clinical education and after-sales support to
 maximize product utilization and customer satisfaction.  InServe employs over
 900 field-based employees comprised of nurses, medical technicians and other
 clinicians who visit hospitals and alternate-site institutions. InServe's
 clients include many of the leading medical device and diagnostics companies,
 including Becton Dickinson, Roche Diagnostics and Johnson & Johnson. The
 transaction is expected to be neutral to PDI's consolidated earnings in 2001
 and 2002. InServe's 2001 net revenue is expected to be between $10 and
 $11 million.
     The worldwide medical device and diagnostics industry is a $180 billion
 market expected to grow to $250 billion by the end of 2004. Lloyd Fishman, a
 24-year veteran of the medical device industry, has been named Vice President
 and General Manager for PDI's Medical Devices & Diagnostics division. Mr.
 Fishman has held senior positions in sales, marketing, and business
 development with both small and large companies.  Most recently he was with
 Johnson & Johnson where he headed worldwide marketing for their vascular
 access business unit.
     PDI's Medical Devices & Diagnostics Division will provide fully integrated
 sales and marketing solutions specifically designed for the medical device &
 diagnostics industries. InServe's expertise in after-sales support completes a
 total value proposition that PDI believes will help it to design complete
 marketing solutions for medical device & diagnostics companies.
     According to PDI Vice Chairman and CEO, Charles T. Saldarini, "PDI has
 always been on the leading edge of our industry in looking for new ways to
 grow.  We believe we can leverage our industry leading sales and marketing
 capabilities together with InServe's to provide another platform for growth.
 The acquisition of InServe demonstrates our commitment to expanding our
 business model.  We now have the ability to access acute care institutions
 which will positively impact all segments of our business".
     About PDI
     PDI is an innovative sales and marketing company serving the
 pharmaceutical, biotech, and medical devices & diagnostics industries.
 Partnering with clients, PDI provides product-specific plans designed to
 maximize profitability throughout a product's lifecycle from pre-launch
 through maturity. With proven industry experience and over 5,000 sales and
 marketing professionals, PDI has the demonstrated ability to deliver results.
     The Company is recognized as an industry-leader based on its track record
 of innovation and its ability to keep pace in a rapidly changing industry. PDI
 leverages its expertise in sales, brand management and product marketing,
 marketing research, medical education, medical affairs, and managed markets
 and trade relations to create solutions that meet strategic objectives and
 provide incremental value for product sales.
     For more information, visit the Company's website at
     Safe Harbor
     In accordance with the safe harbor provisions of the Private Securities
 Litigation Reform Act of 1995, the Company notes that statements in this
 release which look forward in time involve risks and uncertainties that may
 cause actual results or achievements to materially differ from those indicated
 by the forward-looking statements. The Company's plans and objectives are
 based on assumptions involving judgments with respect to future economic,
 competitive and market conditions and future business decisions, all of which
 are difficult or impossible to predict accurately and many of which are beyond
 the control of the Company. Therefore, there can be no assurance that the
 forward-looking statements will prove to be accurate. The Company's documents
 filed with the SEC identify important factors that may cause the actual
 results to differ materially from those indicated by the forward-looking
                     MAKE YOUR OPINION COUNT -  Click Here